- Home
- GEG vs INO Comparison
GEG vs INO Comparison
Compare GEG & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- INO
- Stock Information
- Founded
- GEG 1994
- INO 1979
- Country
- GEG United States
- INO United States
- Employees
- GEG N/A
- INO N/A
- Industry
- GEG Computer Software: Prepackaged Software
- INO Medical/Dental Instruments
- Sector
- GEG Technology
- INO Health Care
- Exchange
- GEG Nasdaq
- INO Nasdaq
- Market Cap
- GEG 72.4M
- INO 69.3M
- IPO Year
- GEG N/A
- INO 1998
- Fundamental
- Price
- GEG $2.99
- INO $2.27
- Analyst Decision
- GEG
- INO Buy
- Analyst Count
- GEG 0
- INO 5
- Target Price
- GEG N/A
- INO $8.80
- AVG Volume (30 Days)
- GEG 894.7K
- INO 2.7M
- Earning Date
- GEG 11-10-2025
- INO 11-13-2025
- Dividend Yield
- GEG N/A
- INO N/A
- EPS Growth
- GEG N/A
- INO N/A
- EPS
- GEG 0.38
- INO N/A
- Revenue
- GEG $16,315,999.00
- INO $182,337.00
- Revenue This Year
- GEG N/A
- INO N/A
- Revenue Next Year
- GEG N/A
- INO $15,775.73
- P/E Ratio
- GEG $7.47
- INO N/A
- Revenue Growth
- GEG N/A
- INO N/A
- 52 Week Low
- GEG $1.70
- INO $1.30
- 52 Week High
- GEG $3.51
- INO $7.00
- Technical
- Relative Strength Index (RSI)
- GEG 64.49
- INO 51.01
- Support Level
- GEG $2.58
- INO $2.33
- Resistance Level
- GEG $2.99
- INO $2.98
- Average True Range (ATR)
- GEG 0.25
- INO 0.22
- MACD
- GEG 0.01
- INO -0.04
- Stochastic Oscillator
- GEG 49.80
- INO 31.93
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.